Guideline-endorsed follow-up after percutaneous valve therapies-non-attendance of TAVI and MitraClip patients.

IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Herz Pub Date : 2024-10-01 Epub Date: 2024-05-14 DOI:10.1007/s00059-024-05245-2
Frank Patrick Schmidt, Martin Geyer, Efthymios Sotiriou, Yasemin Ardic, Pantea Sadegh, Eberhard Schulz, Thomas Münzel, Ralph Stephan von Bardeleben
{"title":"Guideline-endorsed follow-up after percutaneous valve therapies-non-attendance of TAVI and MitraClip patients.","authors":"Frank Patrick Schmidt, Martin Geyer, Efthymios Sotiriou, Yasemin Ardic, Pantea Sadegh, Eberhard Schulz, Thomas Münzel, Ralph Stephan von Bardeleben","doi":"10.1007/s00059-024-05245-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Percutaneous valve therapies (PVT) are performed on a large number of patients. With increasing procedural volume, the need for follow-up has also increased. Follow-up in the heart valve clinic is endorsed by recent guidelines but utilization is unknown, making resource allocation in the clinic difficult. Central follow-up in valve centers may not be feasible for all patients in the future.</p><p><strong>Methods: </strong>In our center, follow-up for PVT patients is scheduled at 1 month and 12 months after the index procedure. Patients are reminded of their appointment by invitation letters or phone calls. We analyzed 150 consecutive patients who underwent transcutaneous aortic valve implantation (TAVI) and MitraClip implantation (n = 300) at our center.</p><p><strong>Results: </strong>At 1 month, 72.7% of patients attended their follow-up, while at 12 months the rate dropped to 58%. Patients who underwent TAVI were older than the MitraClip patients (82.7 vs. 76.1 years) but had lower mean logEuroSCORE (22.6% vs. 25.9%). There was no significant difference in 1‑year mortality between TAVI and MitraClip patients (20% vs. 17.3%). By contrast, the rate of missed follow-up visits was higher for TAVI compared to MitraClip patients (52% vs. 33.3%; p = 0.002). Female patients less frequently attended follow-up (p = 0.005), whereas age, EuroSCORE, NYHA class, ejection fraction, and health status (EQ-5DVAS) were not predictors of attendance in multivariable analysis. Although the result of the EQ-5D assessment was not associated with mortality or attendance, completing the questionnaire was associated with overall survival (p < 0.001).</p><p><strong>Conclusion: </strong>In our heart valve clinic, we observed a high percentage of missed follow-up appointments (42% at 12 months) despite a structured follow-up plan. Factors significantly associated with non-attendance in multivariable analysis were female gender and having a TAVI rather than MitraClip. Future follow-up concepts should take such findings into account, and decentralized approaches need to be explored.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"371-377"},"PeriodicalIF":1.1000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Herz","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00059-024-05245-2","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/14 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Percutaneous valve therapies (PVT) are performed on a large number of patients. With increasing procedural volume, the need for follow-up has also increased. Follow-up in the heart valve clinic is endorsed by recent guidelines but utilization is unknown, making resource allocation in the clinic difficult. Central follow-up in valve centers may not be feasible for all patients in the future.

Methods: In our center, follow-up for PVT patients is scheduled at 1 month and 12 months after the index procedure. Patients are reminded of their appointment by invitation letters or phone calls. We analyzed 150 consecutive patients who underwent transcutaneous aortic valve implantation (TAVI) and MitraClip implantation (n = 300) at our center.

Results: At 1 month, 72.7% of patients attended their follow-up, while at 12 months the rate dropped to 58%. Patients who underwent TAVI were older than the MitraClip patients (82.7 vs. 76.1 years) but had lower mean logEuroSCORE (22.6% vs. 25.9%). There was no significant difference in 1‑year mortality between TAVI and MitraClip patients (20% vs. 17.3%). By contrast, the rate of missed follow-up visits was higher for TAVI compared to MitraClip patients (52% vs. 33.3%; p = 0.002). Female patients less frequently attended follow-up (p = 0.005), whereas age, EuroSCORE, NYHA class, ejection fraction, and health status (EQ-5DVAS) were not predictors of attendance in multivariable analysis. Although the result of the EQ-5D assessment was not associated with mortality or attendance, completing the questionnaire was associated with overall survival (p < 0.001).

Conclusion: In our heart valve clinic, we observed a high percentage of missed follow-up appointments (42% at 12 months) despite a structured follow-up plan. Factors significantly associated with non-attendance in multivariable analysis were female gender and having a TAVI rather than MitraClip. Future follow-up concepts should take such findings into account, and decentralized approaches need to be explored.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
指南认可的经皮瓣膜治疗后随访--TAVI 和 MitraClip 患者的未随访情况。
背景:经皮瓣膜治疗(PVT)的患者人数众多。随着手术量的增加,随访需求也随之增加。心脏瓣膜门诊的随访得到了近期指南的认可,但随访的利用率尚不清楚,这使得门诊的资源分配变得困难。瓣膜中心的集中随访今后可能无法满足所有患者的需求:在我们中心,PVT 患者的随访安排在指数手术后 1 个月和 12 个月。我们通过邀请函或电话提醒患者进行预约。我们分析了在本中心接受经皮主动脉瓣植入术(TAVI)和 MitraClip 植入术的 150 名连续患者(n = 300):1个月后,72.7%的患者接受了随访,12个月后,这一比例降至58%。接受TAVI的患者年龄比MitraClip患者大(82.7岁对76.1岁),但平均logEuroSCORE较低(22.6%对25.9%)。TAVI 和 MitraClip 患者的 1 年死亡率没有明显差异(20% 对 17.3%)。相比之下,TAVI 患者错过随访的比例高于 MitraClip 患者(52% 对 33.3%;P = 0.002)。女性患者参加随访的频率较低(p = 0.005),而年龄、EuroSCORE、NYHA分级、射血分数和健康状况(EQ-5DVAS)在多变量分析中并不是预测参加随访的因素。虽然 EQ-5D 评估结果与死亡率或就诊率无关,但完成问卷调查与总生存率有关(P 结论:EQ-5DVAS 与就诊率无关:在我们的心脏瓣膜门诊中,尽管制定了结构化的随访计划,但我们发现错过随访预约的比例很高(12 个月时为 42%)。在多变量分析中,女性性别和进行 TAVI 而非 MitraClip 与未参加随访明显相关。未来的随访概念应考虑到这些发现,并需要探索分散的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Herz
Herz 医学-心血管系统
CiteScore
3.00
自引率
5.90%
发文量
61
审稿时长
4-8 weeks
期刊介绍: Herz is the high-level journal for further education for all physicians interested in cardiology. The individual issues of the journal each deal with specific topics and comprise review articles in English and German written by competent and esteemed authors. They provide up-to-date and comprehensive information concerning the speciality dealt with in the issue. Due to the fact that all relevant aspects of the pertinent topic of an issue are considered, an overview of the current status and progress in cardiology is presented. Reviews and original articles round off the spectrum of information provided.
期刊最新文献
E-cigarettes and vaping, new spotlight on smoking as an old cardiovascular risk factor? Alcohol consumption-none is better than a little. Effects of cannabis use on the heart. Erratum to: Efficacy of sacubitril-valsartan vs. angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in preventing atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis. Methamphetamine-induced cardiotoxicity: in search of protective transcriptional mechanisms.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1